[Update] Previously covered: 2026-03-30, MRR change: +25.6%

Signal: TrimRx

1. Market Segment

Telehealth / Weight Management — Online GLP-1 medication prescribing platform. The segment has seen explosive growth driven by the Ozempic boom.

2. Case Study

TrimRx: A telehealth company focused on GLP-1 weight loss, founded by Cris, MRR $338,096.

3. Data Sources

• TrustMRR: MRR $338,096, ranked #3, 54% MoM growth
• Previous MRR: $269,051 (2026-03-30) → +$69,045 (+25.6%)
• Source: TrustMRR

4. Opportunity Analysis

TrimRx grew MRR by +25.6% in just 11 days — the strongest growth signal this period. The GLP-1 boom continues, but regulatory risk and competition from major players (Hims $200M+) warrant caution. Adjacent SaaS tools (patient management, drug tracking, remote follow-up) may be the entry point for non-medical founders.